Prognostic impact of platelet indices for advanced non-small cell lung cancer: A retrospective analysis.

Prognostic impact of platelet indices for advanced non-small cell lung cancer: A retrospective analysis. - Platelet indices in NSCLC.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010287

Enrollment

268

Registered

2013-03-22

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced non small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Histologicaly or cytologicaly diagnosed NSCLC. Stage IIIb or IV at initial diagnosis. Patients of NSCLC who received medical examination and treatment at Kansai Medical University Takii Hospital from January 2002 to December 2012.

Exclusion criteria

Exclusion criteria: Patients who lack adequate medical record. Patients who received thoracic irradiation with curative intention. Patients who were diagnosed as LC-NEC.

Design outcomes

Primary

Measure	Time frame
Contribution of platelet indices for survival.	—

Secondary

Measure	Time frame
Characteristics of platelet indices in non small cell lung cancer.	—

Countries

Japan

Contacts

Public ContactToshiki Shimizu

Kansai Medical University 1st department of internal medicine

shimizto@takii.kmu.ac.jp06-6992-1001

Outcome results